Baird Downgrades Cooper Companies to Neutral, Lowers Price Target to $61
Baird analyst Jeff Johnson downgrades Cooper Companies (NASDAQ:COO) from Outperform to Neutral and lowers the price target from $85 to $61.
News
Current market catalysts
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
Latest Headlines
30 headlines
Iran Has Ordered A Temporary Suspension Of Its 10% Freight Charge On Foreign Vessels Carrying Energy Products To Or From Iran
– Reuters cites Fars News Agency
Macy's Sees Q3 Adj EPS $(0.23)-$(0.19) vs $(0.06) Est; Sees Sales $4.650B-$4.700B vs $4.680B Est
Macy's (NYSE:M) is looking for Q3 Adj EPS of $(0.23)-$(0.19) vs $(0.06) analyst estimate. sees sales of $4.650 billion-$4.700 billion vs $4.680 billion analyst estimate.
Macy’s Receives All Expected IEEPA Tariff Refunds, Including $98M In Q2 2026 And $18M After The Quarter's End, For Total Of $116M
The company is taking a balanced approach to deploying benefits. Approximately $20 million of proceeds will flow to full year EPS. The remaining refunds of $96 million are being invested in 2026 to deliver for our
8-K filing — Macy's, Inc. (M)
Filed: 2026-09-10 AccNo: 0001628280-26-061217 Size: 576 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Macy's Raises FY2026 Adj EPS Guidance from $2.00-$2.20 to $2.15-$2.35 vs $2.25 Est; Raises FY2026 Sales Guidance from $21.500B-$21.750B to $21.675B-$21.825B vs $21.914B Est
Macy's (NYSE:M) raises FY2026 Adj EPS guidance from $2.00-$2.20 to $2.15-$2.35 vs $2.25 analyst estimate. Raises FY2026 sales outlook from $21.500 billion-$21.750 billion to $21.675 billion-$21.825 billion vs
Macy's Q2 Adj. EPS $0.40 Beats $0.37 Estimate, Sales $4.866B Beat $4.826B Estimate
Macy's (NYSE:M) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.37 by 8.11 percent. This is a 2.44 percent decrease over earnings of $0.41 per share from the same
Stifel Reinstates Buy on Targa Resources, Announces $340 Price Target
Stifel analyst Robert Hodges reinstates Targa Resources (NYSE:TRGP) with a Buy and announces $340 price target.
Nokia Unveils Cognitive Operations To Bring AI Intelligence Into Fields
Nokia launches Cognitive Operations to deliver real-time intelligence through AI assistance, 3D digital twins, video analytics, predictive maintenance and hybrid connectivity.
Stifel Reinstates Buy on TXO Partners, Announces $17 Price Target
Stifel analyst Robert Hodges reinstates TXO Partners (NYSE:TXO) with a Buy and announces $17 price target.
8-K filing — Designer Brands Inc. (DBI)
Filed: 2026-09-10 AccNo: 0001319947-26-000048 Size: 605 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Chemours, DuPont De Nemours And Corteva Reach Settlement State Of North Carolina And 11 Local Entities; Overall Settlement Payments Total $455M Over 15 Years, With Chemours' 50% Share Of Payments Of ~$180M On NPV Basis Covered By Existing Accruals
The Chemours Company (NYSE:CC) (the "Company") today announced that, along with DuPont de Nemours, Inc. ("Dupont") and Corteva, Inc. ("Corteva"), it has entered into a settlement (the
Needham Reiterates Buy on AeroVironment, Maintains $225 Price Target
Needham analyst Austin Bohlig reiterates AeroVironment (NASDAQ:AVAV) with a Buy and maintains $225 price target.
Designer Brands Raises FY2026 GAAP EPS Guidance from $0.28-$0.38 to $0.47-$0.52 vs $0.39 Est; Raises FY2026 Sales Guidance from $2.868B-$2.926B to $2.897B-$2.926B vs $2.909B Est
Designer Brands (NYSE:DBI) raises FY2026 GAAP EPS guidance from $0.28-$0.38 to $0.47-$0.52 vs $0.39 analyst estimate. Raises FY2026 sales outlook from $2.868 billion-$2.926 billion to $2.897 billion-$2.926 billion vs
8-K filing — Chemours Co (CC)
Filed: 2026-09-10 AccNo: 0001627223-26-000029 Size: 926 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Designer Brands Q2 Adj. EPS $0.34 Beats $0.26 Estimate, Sales $730.631M Miss $744.660M Estimate
Designer Brands (NYSE:DBI) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.26 by 30.77 percent. This is unchanged from the same period last year. The company reported
1-800-Flowers.com Q4 Adj. EPS $(0.80) Misses $(0.69) Estimate, Sales $293.118M Miss $293.596M Estimate
1-800-Flowers.com (NASDAQ:FLWS) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.69) by 15.94 percent. This is a 15.94 percent decrease over losses of $(0.69) per share
Needham Maintains Buy on Cooper Companies, Lowers Price Target to $73
Needham analyst David Saxon maintains Cooper Companies (NASDAQ:COO) with a Buy and lowers the price target from $86 to $73.
The $100 Oil Tipping Point: The Economy Is Running Out of Shock Absorbers
Oil hits $100 as the US-Iran war squeezes markets. Will AI growth prevent a recession, or is stagflation next? Read the IMF warning.
HC Wainwright & Co. Reiterates Buy on Seaport Therapeutics, Maintains $50 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Seaport Therapeutics (NASDAQ:SPTX) with a Buy and maintains $50 price target.
Compass Pathways Announces U.S. Healthcare Provider Grant Program Recipients To Create Training For Delivery Of Psychedelic Treatments
These programs are intended to address both the need for foundational training in psychedelics, as well as ensuring HCPs are well-prepared to care for patients receiving treatment with COMP360 following its expected
HC Wainwright & Co. Maintains Buy on Tyra Biosciences, Lowers Price Target to $30
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and lowers the price target from $45 to $30.
'White House copper tariff plan stalls amid affordability concerns, sources say' - Reuters Exclusive
https://www.reuters.com/world/us/white-house-copper-tariff-plan-stalls-amid-affordability-concerns-sources-say-2026-09-10/
Senator Chris Murphy Sounds Alarm on AI Race, Backs Anthropic Researcher's Warning: 'AI Companies In a Blind Race to Build a Death Machine First'
Murphy backs Anthropic researcher’s warning on AI’s dangerous race toward superintelligence and calls for government oversight.
HC Wainwright & Co. Reiterates Neutral on BioMarin Pharmaceutical, Maintains $60 Price Target
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates BioMarin Pharmaceutical (NASDAQ:BMRN) with a Neutral and maintains $60 price target.
'Nasdaq Invests in Kraken Parent Payward at $21 Billion Valuation' - Bloomberg
https://www.bloomberg.com/news/articles/2026-09-10/nasdaq-invests-in-kraken-parent-payward-at-21-billion-valuation
Akamai Expands Technology Collaboration With MuleSoft Extending Governance Across Apis, Agents, And MCP Servers
Expanded bidirectional integration connects Akamai API Security intelligence with Agent Fabric, extending governance across APIs, agents, and MCP serversHelps organizations discover, understand, and govern APIs and MCP
Elon Musk's Boring Company Raises $3 Billion at $23 Billion Valuation, Plans Over 93 Miles of UAE Tunnels
Elon Musk's The Boring Co. raises $3B from UAE-led investors, reaching a $23B valuation to build 150km+ of tunnels.
Empire Co Q1 EPS $1.04 Beats $0.96 Estimate, Sales $8.475B Miss $8.543B Estimate
Empire Co (TSX:EMP) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.96 by 8.33 percent. This is a 14.29 percent increase over earnings of $0.91 per share from the same
Biohaven Discloses That FDA Demanded Pause In BHV7000-303 Enrolment; Dosing Continues And Topline Data Readout Remains On Timeline For H2 2026
In June 2026, we announced that enrollment in BHV7000-303 was complete. Dosing continues and topline data readout remains on timeline for the second half of 2026. As part of the nonclinical characterization of certain
- Source
- Source-attributed market-news archive
- Observed
- Checked
- Cadence
- Continuous captured-news feed
- Status
- fresh